An aberrant cytoplasmic sequestration of p53, therefore unable to act as a transcription factor, was found in various cancers including undifferentiated neuroblastoma (Moll et al., 1995) and hepatocellular carcinoma (Ueda et al., 1995). This evidence concerns the gene TP53 and hepatocellular carcinoma.